Rafferty Asset Management, LLC Organogenesis Holdings Inc. Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $46,120 - $79,299	-9,730 Reduced 4.14%	225,075 $1.1 Million
Q1 2022 May 13, 2022	SELL	$6.47 - $9.57 $961,862 - $1.42 Million	-148,665 Reduced 38.77%	234,805 $1.79 Million
Q4 2021 Feb 10, 2022	BUY	$9.02 - $13.5 $2.11 Million - $3.16 Million	234,312 Added 157.09%	383,470 $3.54 Million
Q3 2021 Nov 10, 2021	SELL	$13.71 - $17.18 $320,265 - $401,324	-23,360 Reduced 13.54%	149,158 $2.12 Million
Q2 2021 Aug 10, 2021	BUY	$14.92 - $23.23 $2.57 Million - $4.01 Million	172,518 New	172,518 $2.87 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.